Adjuvant treatment of stage IIIC-IIID (lymph node micrometastasis) acral melanoma with Carelizumab combined with Temozolomide versus Carelizumab alone, in addition of radiation therapy: a single center, open label, randomized, controlled Phase II study

Fudan University Shanghai Cancer Center

Melanoma

Therapy Study

Post-market

A multicenter randomized controlled trial comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric cancer

Phase II clinical study of tislelizumab combined with R-CHOP in the first-line treatment of unspecified EBV-positive diffuse large B-cell lymphoma

Clinical studies of patients with platinum-sensitive ovarian cancer using Fluzoparib maintenance therapy

Fudan University Cancer hospital

Diagnostic Accuracy Test

Post-market

A comparative study of 68GA-FAPI and 18F-FDG in the diagnosis of malignant tumors

Fudan University Shanghai Cancer Center

malignant tumor

Diagnostic Accuracy Test

Premarket

A single-arm, Phase II Study to toripalimab combined with pazopanib in treatment of patients with simple lung metastasis clear cell renal cell carcinoma before operation

Fudan University Shanghai Cancer Center

Efficacy and safety of the GEMOX combined with sintilimab and bevacizumab in the initial unresectable biliary tract cancer

An observational study of ctDNA in evaluating postoperative recurrence and adjuvant treatment efficiency after surgical treatment of colorectal cancer with liver metastasis

Efficacy and safety of the GEMOX regimen in combination with or without tripleizumab for conversion to initially unresectable biliary tract cancer

Efficiency and safety of Anlotinib in platinum resistant or refractory ovarian cancer: a prospective, single arm, single center, exploratory phase 2 clinical trail

Fudan University Shanghai Cancer Center

Diagnostic Accuracy Test

Post-market